Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Oligonucleotide Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Pfizer
Regulus Therapeutics
PCI Biotech
GlaxoSmithKline
Merck
SomaGenics
Alnylam
Ionis Pharmaceuticals
Gilead
miRagen Therapeutics
ContraVir
Arrowhead Pharmaceuticals
By Type:
Others
Antisense/RNAi oligonucleotides
By Application:
Cancer
Neurological disorders
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Oligonucleotide Therapeutics Market Overview 2018-2029
-
1.1 China Oligonucleotide Therapeutics Industry Development Overview
-
1.2 China Oligonucleotide Therapeutics Industry Development History
-
1.3 China Oligonucleotide Therapeutics Industry Market Size (2018-2029)
-
1.4 China Oligonucleotide Therapeutics Market Analysis by Type from Production Side
-
1.4.1 China Oligonucleotide Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China Oligonucleotide Therapeutics Production Volume, Production Value and Growth Rate of Antisense/RNAi oligonucleotides (2018-2029)
-
1.5 China Oligonucleotide Therapeutics Market Analysis by Application from Consumption End
-
1.5.1 China Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
1.5.2 China Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate of Neurological disorders (2018-2029)
-
1.5.3 China Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Oligonucleotide Therapeutics Market Analysis by Region
-
1.6.1 North China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
Chapter 2 China Oligonucleotide Therapeutics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Oligonucleotide Therapeutics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Oligonucleotide Therapeutics Market Status and Competition Analysis in 2023
-
2.2.3 China Oligonucleotide Therapeutics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Oligonucleotide Therapeutics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Oligonucleotide Therapeutics Industry Development
Chapter 3 Oligonucleotide TherapeuticsIndustry Chain Analysis
-
3.1 Oligonucleotide Therapeutics Industry Chain
-
3.2 Oligonucleotide Therapeutics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Oligonucleotide Therapeutics Market
-
3.3 Oligonucleotide Therapeutics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Oligonucleotide Therapeutics Market
Chapter 4 China Oligonucleotide Therapeutics Market, by Type
-
4.1 China Oligonucleotide Therapeutics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Oligonucleotide Therapeutics Total Production Volume and Growth Rate from Production Side
-
4.5 China Oligonucleotide Therapeutics Production Volume and Growth Rate, by Type
-
4.5.1 China Oligonucleotide Therapeutics Production Volume and Growth Rate of Others
-
4.5.2 China Oligonucleotide Therapeutics Production Volume and Growth Rate of Antisense/RNAi oligonucleotides
Chapter 5 China Oligonucleotide Therapeutics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Oligonucleotide Therapeutics Total Market Size and Growth Rate from Consumption End
-
5.5 China Oligonucleotide Therapeutics Market Size and Growth Rate, by Application
-
5.5.1 China Oligonucleotide Therapeutics Market Size and Growth Rate of Cancer
-
5.5.2 China Oligonucleotide Therapeutics Market Size and Growth Rate of Neurological disorders
-
5.5.3 China Oligonucleotide Therapeutics Market Size and Growth Rate of Others
Chapter 6 China Oligonucleotide Therapeutics Market, by Region
-
6.1 China Oligonucleotide Therapeutics Production Volume and Production Value, by Region
-
6.2 China Oligonucleotide Therapeutics Sales Volume and Sales Value, by Region
Chapter 7 North China Oligonucleotide Therapeutics Market Analysis
-
7.1 North China Oligonucleotide Therapeutics Market, by Type
-
7.2 North China Oligonucleotide Therapeutics Market, by Application
Chapter 8 Central China Oligonucleotide Therapeutics Market Analysis
-
8.1 Central China Oligonucleotide Therapeutics Market, by Type
-
8.2 Central China Oligonucleotide Therapeutics Market, by Application
Chapter 9 South China Oligonucleotide Therapeutics Market Analysis
-
9.1 South China Oligonucleotide Therapeutics Market, by Type
-
9.2 South China Oligonucleotide Therapeutics Market, by Application
Chapter 10 East China Oligonucleotide Therapeutics Market Analysis
-
10.1 East China Oligonucleotide Therapeutics Market, by Type
-
10.2 East China Oligonucleotide Therapeutics Market, by Application
Chapter 11 Northeast China Oligonucleotide Therapeutics Market Analysis
-
11.1 Northeast China Oligonucleotide Therapeutics Market, by Type
-
11.2 Northeast China Oligonucleotide Therapeutics Market, by Application
Chapter 12 Southwest China Oligonucleotide Therapeutics Market Analysis
-
12.1 Southwest China Oligonucleotide Therapeutics Market, by Type
-
12.2 Southwest China Oligonucleotide Therapeutics Market, by Application
Chapter 13 Northwest China Oligonucleotide Therapeutics Market Analysis
-
13.1 Northwest China Oligonucleotide Therapeutics Market, by Type
-
13.2 Northwest China Oligonucleotide Therapeutics Market, by Application
Chapter 14 Company Profiles
-
14.1 Pfizer
-
14.1.1 Pfizer Company Profile
-
14.1.2 Pfizer Oligonucleotide Therapeutics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Regulus Therapeutics
-
14.2.1 Regulus Therapeutics Company Profile
-
14.2.2 Regulus Therapeutics Oligonucleotide Therapeutics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 PCI Biotech
-
14.3.1 PCI Biotech Company Profile
-
14.3.2 PCI Biotech Oligonucleotide Therapeutics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Profile
-
14.4.2 GlaxoSmithKline Oligonucleotide Therapeutics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Merck
-
14.5.1 Merck Company Profile
-
14.5.2 Merck Oligonucleotide Therapeutics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 SomaGenics
-
14.6.1 SomaGenics Company Profile
-
14.6.2 SomaGenics Oligonucleotide Therapeutics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Alnylam
-
14.7.1 Alnylam Company Profile
-
14.7.2 Alnylam Oligonucleotide Therapeutics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Ionis Pharmaceuticals
-
14.8.1 Ionis Pharmaceuticals Company Profile
-
14.8.2 Ionis Pharmaceuticals Oligonucleotide Therapeutics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Gilead
-
14.9.1 Gilead Company Profile
-
14.9.2 Gilead Oligonucleotide Therapeutics Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 miRagen Therapeutics
-
14.10.1 miRagen Therapeutics Company Profile
-
14.10.2 miRagen Therapeutics Oligonucleotide Therapeutics Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 ContraVir
-
14.11.1 ContraVir Company Profile
-
14.11.2 ContraVir Oligonucleotide Therapeutics Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Arrowhead Pharmaceuticals
-
14.12.1 Arrowhead Pharmaceuticals Company Profile
-
14.12.2 Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Market Performance
-
14.12.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Oligonucleotide Therapeutics Industry Research Conclusions
-
15.2 Oligonucleotide Therapeutics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Oligonucleotide Therapeutics Industry Market Size (2018-2029)
-
Figure China Oligonucleotide Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Oligonucleotide Therapeutics Production Volume, Production Value and Growth Rate of Antisense/RNAi oligonucleotides (2018-2029)
-
Figure China Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
Figure China Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate of Neurological disorders (2018-2029)
-
Figure China Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Central China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure South China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure East China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Oligonucleotide Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Oligonucleotide Therapeutics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Oligonucleotide Therapeutics Market Share by Type in 2018
-
Figure China Oligonucleotide Therapeutics Market Share by Type in 2023
-
Figure China Oligonucleotide Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Oligonucleotide Therapeutics Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Oligonucleotide Therapeutics Production Volume and Growth Rate of Antisense/RNAi oligonucleotides (2018-2023)
-
Figure China Oligonucleotide Therapeutics Market Share by Application in 2018
-
Figure China Oligonucleotide Therapeutics Market Share by Application in 2023
-
Figure China Oligonucleotide Therapeutics Total Market Size and Growth Rate from Consumption End
-
Figure China Oligonucleotide Therapeutics Market Size and Growth Rate of Cancer (2018-2023)
-
Figure China Oligonucleotide Therapeutics Market Size and Growth Rate of Neurological disorders (2018-2023)
-
Figure China Oligonucleotide Therapeutics Market Size and Growth Rate of Others (2018-2023)
-
Table China Oligonucleotide Therapeutics Production Volume by Region (2018-2023)
-
Table China Oligonucleotide Therapeutics Production Volume Share by Region (2018-2023)
-
Figure China Oligonucleotide Therapeutics Production Volume Share by Region (2018-2023)
-
Table China Oligonucleotide Therapeutics Production Value by Region (2018-2023)
-
Table China Oligonucleotide Therapeutics Production Value Share by Region (2018-2023)
-
Figure China Oligonucleotide Therapeutics Production Value Share by Region (2018-2023)
-
Table China Oligonucleotide Therapeutics Sales Volume by Region (2018-2023)
-
Table China Oligonucleotide Therapeutics Sales Volume Share by Region (2018-2023)
-
Figure China Oligonucleotide Therapeutics Sales Volume Share by Region (2018-2023)
-
Table China Oligonucleotide Therapeutics Sales Value by Region (2018-2023)
-
Table China Oligonucleotide Therapeutics Sales Value Share by Region (2018-2023)
-
Figure China Oligonucleotide Therapeutics Sales Value Share by Region (2018-2023)
-
Table North China Oligonucleotide Therapeutics Production Volume by Type (2018-2023)
-
Table North China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Figure North China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Table North China Oligonucleotide Therapeutics Sales Volume by Application (2018-2023)
-
Table North China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure North China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Central China Oligonucleotide Therapeutics Production Volume by Type (2018-2023)
-
Table Central China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Central China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Table Central China Oligonucleotide Therapeutics Sales Volume by Application (2018-2023)
-
Table Central China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Central China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Table South China Oligonucleotide Therapeutics Production Volume by Type (2018-2023)
-
Table South China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Figure South China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Table South China Oligonucleotide Therapeutics Sales Volume by Application (2018-2023)
-
Table South China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure South China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Table East China Oligonucleotide Therapeutics Production Volume by Type (2018-2023)
-
Table East China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Figure East China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Table East China Oligonucleotide Therapeutics Sales Volume by Application (2018-2023)
-
Table East China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure East China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Oligonucleotide Therapeutics Production Volume by Type (2018-2023)
-
Table Northeast China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northeast China Oligonucleotide Therapeutics Sales Volume by Application (2018-2023)
-
Table Northeast China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Oligonucleotide Therapeutics Production Volume by Type (2018-2023)
-
Table Southwest China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Table Southwest China Oligonucleotide Therapeutics Sales Volume by Application (2018-2023)
-
Table Southwest China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Oligonucleotide Therapeutics Production Volume by Type (2018-2023)
-
Table Northwest China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Oligonucleotide Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northwest China Oligonucleotide Therapeutics Sales Volume by Application (2018-2023)
-
Table Northwest China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Oligonucleotide Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Regulus Therapeutics Company Profile
-
Table Regulus Therapeutics Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table PCI Biotech Company Profile
-
Table PCI Biotech Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table SomaGenics Company Profile
-
Table SomaGenics Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Alnylam Company Profile
-
Table Alnylam Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Ionis Pharmaceuticals Company Profile
-
Table Ionis Pharmaceuticals Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Gilead Company Profile
-
Table Gilead Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table miRagen Therapeutics Company Profile
-
Table miRagen Therapeutics Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table ContraVir Company Profile
-
Table ContraVir Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Arrowhead Pharmaceuticals Company Profile
-
Table Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Revenue, Price and Gross (2018-2023)
-
